Residual Postoperative Pneumoperitoneum

Definition

Mechanism and Gas Kinetics

• Rapidly absorbed across the peritoneal membrane into the circulation
• Highly soluble in blood (lowers the risk of gas embolism)
• Rapidly excreted via the lungs
• Colorless, odorless, inexpensive, and non-combustible
• Hinman's Atlas of Urologic Surgery, p. PNEUOPERITONEUM section

• Is absorbed progressively over 24-72 hours in most patients
• Can persist longer depending on the volume insufflated, duration of surgery, and patient's peritoneal surface area and respiratory reserve
• Nitrogen-containing air, if used historically, is absorbed far more slowly (nitrogen is poorly soluble in blood), which is why CO2 replaced air as the standard insufflant
• Schwartz's Principles of Surgery 11e, p. Laparoscopy section

Clinical Significance and Symptoms

1. Shoulder Tip Pain (Most Common Symptom)

"This also explains why patients frequently complain of shoulder tip pain following laparoscopic or robotic surgery." - Bailey and Love's Short Practice of Surgery 28e

2. Upper Abdominal Discomfort

3. Pleuritic-Type Chest Discomfort

4. Nausea

• Barash Clinical Anesthesia 9e, p. Postoperative Management

Radiology

• Free air under the right hemidiaphragm (most common) - a crescentic lucent shadow
• Can be bilateral

• Anastomotic leak
• Bowel perforation (missed or new)
• Ongoing enteric fistula

Risk Factors for Prolonged or Symptomatic Residual Pneumoperitoneum

Prevention

1. Lower insufflation pressure (IAP) - use the minimum pressure needed (typically 8-12 mmHg rather than 15 mmHg)
2. Active evacuation of subdiaphragmatic CO2 before wound closure - placing the patient in the Trendelenburg position and manually compressing the abdomen while ports are still open
3. Shorter duration of pneumoperitoneum (efficient surgery)
4. Intraperitoneal saline instillation (dilutes CO2, some evidence it reduces shoulder tip pain)
5. Aspiration of residual gas through a port before final removal

• Barash Clinical Anesthesia 9e: "A number of surgical techniques during laparoscopy can reduce the severity of postoperative pain. These include the use of lower IAP, shorter duration of pneumoperitoneum, and evacuation of subdiaphragmatic CO2 prior to wound closure."

Management of Symptoms

When to Be Concerned (Red Flags)

• Fever, tachycardia, peritonism - suggest anastomotic leak, bowel injury, or abscess
• Increasing free air on serial imaging (rather than decreasing)
• New onset of symptoms after an initial asymptomatic period (day 3-5 post-op)
• Port-site tenderness with ileus on day 2-3 - consider bowel entrapment at port site (requires re-exploration)

"If missed during the process of cannula removal, then in the early postoperative period, usually on the second or third postoperative day, the patient may develop an ileus and point tenderness at the port site incision. The treatment is operative." - Campbell Walsh Wein Urology

Summary

38F: Fever 12 Days + Joint Pain + Rash (Day 4-5)

Clinical Summary

Differential Diagnosis

1. Adult-Onset Still's Disease (AOSD) - Top Differential

• High spiking fever (≥39°C), quotidian (once daily) or double-quotidian (twice daily)
• Salmon-pink evanescent maculopapular rash - characteristically appears when the patient is febrile and disappears when afebrile
• Arthralgia / arthritis (knees, wrists, ankles, elbows - DIP joints also involved, which is unusual)

• Nonsuppurative pharyngitis (sore throat)
• Lymphadenopathy, hepatosplenomegaly
• Leukocytosis (neutrophilic)
• Markedly elevated serum ferritin (often >2000 ng/mL) - characteristic and diagnostically helpful
• Can present as fever of unknown origin (FUO) in up to 10% of cases

"AOSD is a systemic inflammatory disorder of unknown etiology. It occurs worldwide and is associated with a bimodal age distribution with peaks between the ages 15-25 years and 36-46 years. The rash often appears when the patient is febrile and disappears during afebrile periods." - Frameworks for Internal Medicine

2. Parvovirus B19 Infection - Strong Contender

• Prodrome of fever, malaise, headache, myalgia lasting several days - then rash and arthritis appear (mirrors this case exactly)
• Symmetric polyarthritis - elbows, wrists, knees, ankles, feet
• Peripheral macular rash lasting 2-3 days; multiple morphologies described
• Arthropathy occurs in ~30% of adult infections; rash in ~35%
• Important trap: ANA can be transiently elevated - can mimic SLE
• Both parvovirus and SLE are more common in women - differentiation requires parvovirus IgM serology

"Parvovirus clearly fits this patient's presentation... She was treated with NSAIDs with good relief of her symptoms. Her rash resolved over 3-4 days, and joint pain was gone at a follow-up visit 2 weeks later." - Symptom to Diagnosis, 4th Edition

3. Systemic Lupus Erythematosus (SLE) - Must Not Miss

• More common in women (9:1), peak reproductive age
• Fever, arthritis/arthralgia, and rash (malar butterfly rash, photosensitive)
• Leukopenia, ANA positive, anti-dsDNA (specific), low complement
• Diagnosis requires ≥4 of 11 ACR criteria (or SLICC criteria)
• Must be excluded before diagnosing AOSD or viral arthritis
• Key distinction: ANA in SLE is persistently positive and at high titer; in parvovirus B19 it is transient

4. Acute Rheumatic Fever (ARF) - Must Not Miss

• Fever then migratory polyarthritis (large joints - knees, ankles, hips, elbows)
• Erythema marginatum (ring-shaped rash, trunk and limbs, not face) - appears with fever
• Other Jones criteria: carditis, Sydenham's chorea, subcutaneous nodules
• Highly responsive to NSAIDs/aspirin (characteristic)
• Requires evidence of preceding GAS infection: elevated ASO/anti-DNase B, positive throat culture

"Arthritis in acute rheumatic fever is classically asymmetric, migratory, and inflammatory, affecting the large joints most frequently. It is highly responsive to salicylates and other NSAIDs." - Frameworks for Internal Medicine

5. Viral Arthritis - Other Causes

6. Reactive Arthritis (ReA)

• Arthritis occurring 1-4 weeks after enteric (Salmonella, Shigella, Yersinia, Campylobacter) or urogenital (Chlamydia) infection
• Classic triad: arthritis + urethritis + conjunctivitis (Reiter's syndrome)
• Rash: keratoderma blennorrhagica (palms/soles), circinate balanitis
• Ask about preceding GI illness or urogenital symptoms

Approach to This Patient

History to Elicit

• Character of fever: Is it spiking and quotidian? Does the rash appear only with fever spikes? (AOSD)
• Rash description: Salmon-pink and evanescent vs. malar butterfly vs. erythema marginatum vs. maculopapular peripheral
• Joint pattern: Migratory (ARF) vs. symmetric (parvovirus) vs. additive (AOSD)
• Throat soreness (AOSD, ARF)
• Travel history (dengue, chikungunya)
• Contact with children (parvovirus B19)
• Prior GAS infection (ARF)
• GI/urogenital symptoms (reactive arthritis)
• Photosensitivity, oral ulcers, hair loss (SLE)
• Drug history (drug-induced lupus, serum sickness)

Investigations (First-Line)

ECG / Echo

Summary: Most Likely Diagnoses in Order

1. Parvovirus B19 - fever preceding rash + arthritis by days, symmetric polyarthritis, female in reproductive age group - classically fits
2. Adult-Onset Still's Disease - 38-year age peak, quotidian fever, evanescent salmon rash with fever spikes, markedly elevated ferritin
3. SLE - female, rash + arthritis + fever; must be excluded with ANA/anti-dsDNA
4. Acute Rheumatic Fever - if migratory large-joint arthritis and preceding sore throat
5. Viral arthritis (dengue/chikungunya) - if travel history present

• Symptom to Diagnosis, 4th Edition
• Frameworks for Internal Medicine
• Goldman-Cecil Medicine
• Dermatology 2-Volume Set 5e

Renal Cell Carcinoma (RCC) - Diagnosis

Epidemiology

• ~81,000 new cases/year in the United States; ~15,000 deaths/year
• 7th most common cancer overall; 6th in males, 9th in females
• Male : Female ratio ~2:1
• Peak incidence: 55-75 years
• Incidence highest in Black Americans; lowest in Asian/Pacific Islanders
• Only 4-6% of cases are familial; the majority are sporadic

• Goldman-Cecil Medicine; Harrison's Principles 22e; Sabiston Textbook of Surgery

Histological Classification

"The metastatic potential depends on the histologic subtype and ranges from the most virulent conventional clear cell carcinomas (65% of total tumors but accounting for 90% of the metastases), to the more indolent papillary and chromophobe carcinomas (25% of the total but only 10% of the metastases)." - Goldman-Cecil Medicine

Hereditary Syndromes Associated with RCC

• Harrison's Principles of Internal Medicine 22e

Clinical Presentation

Classic Triad (Virchow's Triad of RCC)

1. Flank/costovertebral pain
2. Gross hematuria
3. Palpable flank/abdominal mass

This classic triad is present in only 5-10% of cases and usually indicates advanced, locally advanced disease.

Incidental Discovery

• >50% of RCC is now discovered incidentally on imaging (CT/ultrasound) performed for unrelated reasons
• Despite this, 30% of patients still present with metastatic disease

Symptoms at Advanced Presentation

• Hematuria (most reliable clinical clue - may be intermittent or microscopic)
• Constitutional symptoms: fever, fatigue, weight loss, malaise
• Symptoms of metastasis: pathologic fracture, cough, hemoptysis, neurological symptoms

Paraneoplastic Syndromes (present in ~20% at diagnosis)

"Renal cell carcinoma is considered one of the great mimics in medicine, because it tends to produce a diversity of systemic symptoms not related to the kidney." - Robbins Cotran Kumar Pathologic Basis of Disease

Diagnostic Workup

Step 1 - Initial Labs

Step 2 - Imaging

Ultrasound

• First step for evaluating a renal mass
• Distinguishes simple cysts (benign) from solid masses
• Low sensitivity for small lesions
• Solid or complex cystic lesion on US → proceed to CT/MRI

Contrast-Enhanced CT (CECT) - Primary Diagnostic Modality

• Preferred imaging modality for characterizing renal masses
• Four phases: precontrast → arterial (~25 sec) → nephrographic (~90 sec) → excretory
• Key findings: enhancement on contrast (>15 HU increase) = malignant until proven otherwise
• Evaluates: tumor size, local extension, renal vein and IVC thrombus (critical for staging), regional lymph nodes, adrenal glands
• Macroscopic fat in a solid mass → angiomyolipoma (benign)
• CT chest for pulmonary metastases

• Clear cell RCC: avid enhancement in corticomedullary phase, then hypoenhancing in nephrographic phase ("washout")
• Chromophobe RCC: avid enhancement, but less than clear cell; central scar
• Papillary RCC: hypointense on T2-MRI; hypoenhancing on all phases (hypovascular)

MRI

• Similar diagnostic yield to CT for solid masses
• Superior for: IVC/renal vein thrombus assessment, complex cystic lesions (subtraction imaging detects subtle enhancement), patients with contrast allergy or poor renal function
• MRI angiography: maps renal artery anatomy pre-operatively for partial nephrectomy

Contrast-Enhanced Ultrasound (CEUS)

• New, inexpensive; non-nephrotoxic contrast (microbubbles)
• Clear cell RCC: avid early enhancement + pseudocapsule + early washout
• Useful in patients with reduced GFR

Bone Scan

• Indicated in: clinically advanced disease, bone pain, hypercalcemia, elevated ALP
• Not routine for localized disease

Brain MRI

• Indicated when neurological symptoms are present or clinically suspected metastases

Step 3 - Bosniak Classification for Cystic Renal Masses

"Category III and IV cysts are usually treated as representing renal cell carcinomas." - Sabiston Textbook of Surgery

Step 4 - Renal Mass Biopsy

• Increasingly used before ablative therapy or active surveillance to confirm histology
• Before starting systemic therapy for unresectable/metastatic disease (tissue confirmation required)
• When imaging is equivocal and a benign diagnosis (e.g., lymphoma, metastasis from another primary) would change management

• Diagnostic accuracy ~90% for solid masses
• Not routinely done for cystic lesions (poor yield, sampling error, risk of spillage)
• Non-diagnostic in ~10-15% (may require repeat or surgical excision)
• Needle tract seeding is rare but reported

TNM Staging (AJCC)

• Stage I: T1, N0, M0
• Stage II: T2, N0, M0
• Stage III: T1/T2 N1 M0, or T3 any N M0
• Stage IV: T4 any N M0, or any T any N M1

Histologic Grading

• Grade 1-2: Low grade (favorable)
• Grade 3-4: High grade (grade 4 includes sarcomatoid/rhabdoid differentiation)

Prognosis

• Histologic subtype (clear cell worst, chromophobe best)
• Nuclear grade (Fuhrman/WHO-ISUP)
• Stage (T, N, M)
• Performance status
• Presence of sarcomatoid differentiation (very poor prognosis)

Summary Diagnostic Algorithm

Renal mass found (incidental or symptomatic)
         ↓
    Ultrasound
         ↓
Simple cyst? → No follow-up
Solid/complex? → CECT abdomen/pelvis + CT chest
         ↓
Bosniak I-II → follow-up
Bosniak III-IV → treat as malignant → surgical planning
Solid enhancing mass → stage with TNM
         ↓
If biopsy needed → percutaneous core biopsy (before ablation/surveillance/systemic therapy)
         ↓
Labs: CBC, CMP, LFTs, Ca2+, LDH, UA
Bone scan if: bone pain, hypercalcemia, elevated ALP
Brain MRI if: neurological symptoms

• Robbins Cotran & Kumar Pathologic Basis of Disease
• Harrison's Principles of Internal Medicine 22e
• Goldman-Cecil Medicine
• Campbell Walsh Wein Urology
• Sabiston Textbook of Surgery
• National Kidney Foundation Primer on Kidney Diseases 8e